ResearcherMayo ClinicActive in the last 2 years
Nicole R Murray
Matched on ORCID iD 0000-0002-6833-8273; OpenAlex author ID A5003409853; NIH RePORTER profile ID 6806571. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 2
- Labs led
- 1
- Collaborators
- 8
2011: 1 grant · 2012: none · 2013: 1 paper · 2014: none · 2015: 1 paper, 1 grant · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 3
- Early induction of the Rho-GEF ECT2 drives MEK/ERK oncogenic signaling in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-026-03860-3↗
- A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion. Last author DOI 10.18632/oncotarget.3812↗
- Protein kinase C zeta regulates human pancreatic cancer cell transformed growth and invasion through a STAT3-dependent mechanism. Last author DOI 10.1371/journal.pone.0072061↗
Grants 2
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Verline Justilien · 1 shared paper, 2026 · strength 0.28
- Dania S. Al-Qasrawi · 1 shared paper, 2026 · strength 0.28
- Alicia K. Fleming Martinez · 1 shared paper, 2026 · strength 0.28
- Peter Störz · 1 shared paper, 2026 · strength 0.28
- Amanda Saravia-Butler · 2 shared papers, 2013–2015 · strength 0.10
- Paper A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth an… DOI 10.18632/oncotarget.3812↗
- Paper Protein kinase C zeta regulates human pancreatic cancer cell transformed growth and invasion through a STAT3-dependent … DOI 10.1371/journal.pone.0072061↗
- E. Aubrey Thompson · 1 shared grant, 2011 · strength 0.09
- Michael B. Wallace · 1 shared grant, 2011 · strength 0.09
- Kristin S. Inman · 1 shared paper, 2015 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.